Clinical trial
A Long-term Safety Study of Infliximab in Patients With Moderate to Severe…
NCT00380796 · Centocor, Inc., Industry · Completed
Key facts
| NCT number | NCT00380796 |
|---|---|
| Title | A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). |
| Official title | A Multicenter, Observational Study of the Long-term Safety of Infliximab (REMICADE) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). RESULTS COPD: REMICADE Safety Under Long Term Study in COPD |
| Lead sponsor | Centocor, Inc., Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | COPD, Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | Collection of safety data for Cohort 1 |
| Enrollment | 88 |
| Start date | Apr 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Sep 26, 2006 |
| Last update posted | Sep 4, 2013 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: